Mode
Text Size
Log in / Sign up

Observational study tracks outpatient visits in nonhospitalized adult COVID-19 patients

Observational study tracks outpatient visits in nonhospitalized adult COVID-19 patients
Photo by Judy Beth Morris / Unsplash
Key Takeaway
Note that many nonhospitalized COVID-19 patients seek care for new symptoms months after diagnosis in observational data.

This observational study examined health care utilization and clinical characteristics 28-180 days after COVID-19 diagnosis in 3,171 nonhospitalized adult patients within an integrated health care system in Georgia. The study did not report a specific comparator group, primary outcome, or intervention beyond COVID-19 diagnosis.

The main results showed that 69% of patients had one or more outpatient visits during the 28-180 day follow-up period. Approximately two-thirds of patients had a visit for a new primary diagnosis, and about one-third had a new specialist visit. Symptoms potentially related to COVID-19 were common as new visit diagnoses, with visits for these symptoms decreasing after 60 days but continuing for some patients through 120-180 days. The study did not report specific effect sizes, absolute numbers, p-values, or confidence intervals for these findings.

Safety and tolerability data were not reported. The study has several important limitations: it is observational and can only show associations, not establish causality. The findings may not generalize beyond the specific health system and time period studied. No information was provided about funding or conflicts of interest. For clinical practice, these findings suggest that nonhospitalized COVID-19 patients frequently seek care for new symptoms in the months following diagnosis, but clinicians should interpret these patterns cautiously given the observational nature of the evidence.

Study Details

EvidenceLevel 5
PublishedApr 2021
View Original Abstract ↓
Among 3,171 nonhospitalized adult COVID-19 patients, 69% had one or more outpatient visits 28-180 days after the diagnosis. Two thirds had a visit for a new primary diagnosis, and approximately one third had a new specialist visit. Symptoms potentially related to COVID-19 were common new visit diagnoses. Visits for these symptoms decreased after 60 days but for some patients continued through 120-180 days.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.